• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿酸、尿酸铵和钙基肾结石的比较蛋白质组学分析

Comparative proteomic profiling of uric acid, ammonium acid urate, and calcium-based kidney stones.

作者信息

Khusid Johnathan A, Vasquez Alex, Sadiq Areeba S, Stockert Jennifer A, Gallante Blair, Yaghoubian Alan, Shimonov Roman, Stock Aryeh, Atallah William, Kyprianou Natasha, Yang Wei, Gupta Mantu

机构信息

Icahn School of Medicine at Mount Sinai New York, NY, USA.

Cedars-Sinai Medical Center Los Angeles, CA, USA.

出版信息

Am J Clin Exp Urol. 2023 Jun 15;11(3):265-274. eCollection 2023.

PMID:37441444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10333134/
Abstract

INTRODUCTION

Kidney stone matrix proteins may help explain cellular mechanisms of stone genesis. However, most existing proteomic studies have focused on calcium oxalate stones. Here, we present a comparative proteomic analysis of different kidney stone types.

METHODS

Proteins were extracted from the stones of patients undergoing percutaneous nephrolithotomy (PCNL). Approximately 20 μg of protein was digested into tryptic peptides using filter aided sample preparation, followed by liquid chromatography tandem-mass-spectrometry using an EASY-nLC 1200 and Orbitrap Fusion Lumos mass spectrometer. A standard false discovery rate cutoff of 1% was used for protein identification. Stone analysis was used to organize stone samples into similar groups. We selected the top 5% of proteins based on total ion intensities and used DAVID and Ingenuity Pathway Analysis to identify and compare significantly enriched gene ontologies and pathways between groups.

RESULTS

Six specimens were included and organized into the following four groups: 1) mixed uric acid (UA) and calcium-based, 2) pure UA, 3) pure ammonium acid urate (AAU), and 4) pure calcium-based. We identified 2,426 unique proteins (1,310-1,699 per sample), with 11-16 significantly enriched KEGG pathways identified per group and compared via heatmap. Based on number of unique proteins identified, this is the deepest proteomic study of kidney stones to date and the first such study of an AAU stone.

CONCLUSIONS

The results indicate that mixed UA and calcium-based kidney stones are more similar to pure UA stones than pure calcium-based stones. AAU stones appear more similar to pure calcium-based stones than UA containing stones and may be related to parasitic infections. Further research with larger cohorts and histopathologic correlation is warranted.

摘要

引言

肾结石基质蛋白可能有助于解释结石形成的细胞机制。然而,大多数现有的蛋白质组学研究都集中在草酸钙结石上。在此,我们展示了对不同类型肾结石的比较蛋白质组学分析。

方法

从接受经皮肾镜取石术(PCNL)的患者的结石中提取蛋白质。使用滤膜辅助样品制备将约20μg蛋白质消化成胰蛋白酶肽段,随后使用EASY-nLC 1200和Orbitrap Fusion Lumos质谱仪进行液相色谱串联质谱分析。蛋白质鉴定使用1%的标准错误发现率截断值。通过结石分析将结石样本分组。我们根据总离子强度选择前5%的蛋白质,并使用DAVID和 Ingenuity Pathway Analysis来识别和比较组间显著富集的基因本体和通路。

结果

纳入六个标本并分为以下四组:1)尿酸(UA)和钙混合型,2)纯UA型,3)纯尿酸铵(AAU)型,4)纯钙型。我们鉴定出2426种独特蛋白质(每个样本1310 - 1699种),每组鉴定出11 - 16条显著富集的KEGG通路,并通过热图进行比较。基于鉴定出的独特蛋白质数量,这是迄今为止对肾结石最深层次的蛋白质组学研究,也是对AAU结石的首次此类研究。

结论

结果表明,尿酸和钙混合型肾结石与纯尿酸结石比与纯钙结石更相似。AAU结石似乎比含尿酸结石更类似于纯钙结石,并且可能与寄生虫感染有关。有必要进行更大样本量队列及组织病理学相关性的进一步研究。

相似文献

1
Comparative proteomic profiling of uric acid, ammonium acid urate, and calcium-based kidney stones.尿酸、尿酸铵和钙基肾结石的比较蛋白质组学分析
Am J Clin Exp Urol. 2023 Jun 15;11(3):265-274. eCollection 2023.
2
An Increase Incidence in Uric Acid Nephrolithiasis: Changing Patterns.尿酸肾结石发病率上升:变化趋势
J Clin Diagn Res. 2016 Jul;10(7):BC01-3. doi: 10.7860/JCDR/2016/19714.8139. Epub 2016 Jul 1.
3
Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.“纯”尿酸肾结石患者与“纯”草酸钙结石形成者的临床和生化特征比较。
Urol Res. 2007 Oct;35(5):247-51. doi: 10.1007/s00240-007-0109-1. Epub 2007 Sep 6.
4
Ammonium acid urate crystal formation in adult North American stone-formers.成年北美结石形成者中尿酸铵晶体的形成
Am J Kidney Dis. 1997 Aug;30(2):237-42. doi: 10.1016/s0272-6386(97)90058-5.
5
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation.双能计算机断层扫描用于尿酸结石的鉴别:离体性能评估
Urol Res. 2008 Aug;36(3-4):133-8. doi: 10.1007/s00240-008-0140-x. Epub 2008 Jun 11.
6
Calcium stone disease: a multiform reality.钙结石病:一种多形态的实际情况。
Urol Res. 2005 Jun;33(3):194-8. doi: 10.1007/s00240-004-0459-x.
7
On the protein content of kidney stones: an explorative study.关于肾结石的蛋白质含量:一项探索性研究。
Acta Clin Belg. 2022 Oct;77(5):845-852. doi: 10.1080/17843286.2021.1999569. Epub 2021 Nov 6.
8
Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.比较混合草酸钙/尿酸结石形成者与单纯草酸钙和单纯尿酸结石形成者的代谢特征。
Urology. 2014 Aug;84(2):289-94. doi: 10.1016/j.urology.2014.04.019. Epub 2014 Jun 12.
9
Comparison of matrix proteins in different types of urinary stone by proteomic analysis using liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法通过蛋白质组学分析比较不同类型尿石中的基质蛋白。
Int J Urol. 2012 Aug;19(8):765-72. doi: 10.1111/j.1442-2042.2012.03005.x. Epub 2012 Apr 11.
10
Clinical and biochemical features of uric acid nephrolithiasis.尿酸肾结石的临床及生化特征
Eur Urol. 1995;27(4):324-8. doi: 10.1159/000475190.

引用本文的文献

1
Identifying therapeutic targets for kidney stone disease through proteome-wide Mendelian randomization and colocalization analysis.通过全蛋白质组孟德尔随机化和共定位分析鉴定肾结石病的治疗靶点。
Urolithiasis. 2024 Nov 25;52(1):167. doi: 10.1007/s00240-024-01669-x.
2
Self-control study of multi-omics in identification of microenvironment characteristics in urine of uric acid stone.多组学的自我控制研究鉴定尿酸结石尿液中的微环境特征。
Sci Rep. 2024 Oct 24;14(1):25165. doi: 10.1038/s41598-024-76054-0.

本文引用的文献

1
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.受体相互作用蛋白激酶 2(RIPK2)稳定 c-Myc 并成为前列腺癌转移的治疗靶点。
Nat Commun. 2022 Feb 3;13(1):669. doi: 10.1038/s41467-022-28340-6.
2
BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.方盒车和猎枪蛋白质组学分析揭示了 UBR5 在前列腺癌中调控的分子网络。
Proteomics. 2022 Feb;22(4):e2100172. doi: 10.1002/pmic.202100172. Epub 2021 Dec 23.
3
Proteomic analysis reveals some common proteins in the kidney stone matrix.蛋白质组学分析揭示了肾结石基质中的一些常见蛋白质。
PeerJ. 2021 Jul 27;9:e11872. doi: 10.7717/peerj.11872. eCollection 2021.
4
Beyond Prevalence: Annual Cumulative Incidence of Kidney Stones in the United States.超越流行率:美国肾结石的年累积发病率。
J Urol. 2021 Jun;205(6):1704-1709. doi: 10.1097/JU.0000000000001629. Epub 2021 Jan 27.
5
Roles of Macrophage Exosomes in Immune Response to Calcium Oxalate Monohydrate Crystals.巨噬细胞外泌体在应对一水草酸钙晶体免疫反应中的作用。
Front Immunol. 2018 Feb 27;9:316. doi: 10.3389/fimmu.2018.00316. eCollection 2018.
6
Characterizations of heparin-binding proteins in human urine by affinity purification-mass spectrometry and defining "L-x(2,3)-A-x(0,1)-L" as a novel heparin-binding motif.通过亲和纯化-质谱法对人尿液中的肝素结合蛋白进行表征,并将“L-x(2,3)-A-x(0,1)-L”定义为一种新型肝素结合基序。
J Proteomics. 2016 Jun 16;142:53-61. doi: 10.1016/j.jprot.2016.04.043. Epub 2016 Apr 30.
7
Label-free proteomic methodology for the analysis of human kidney stone matrix composition.用于分析人肾结石基质成分的无标记蛋白质组学方法。
Proteome Sci. 2016 Feb 27;14:4. doi: 10.1186/s12953-016-0093-x. eCollection 2016.
8
Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi.在尿液和肾结石患者结石基质中,经蛋白质组学方法鉴定到的炎症和纤维蛋白在蛋白质组层面被鉴定为关键蛋白成分。
Clin Chim Acta. 2014 Feb 15;429:81-9. doi: 10.1016/j.cca.2013.11.036. Epub 2013 Dec 9.
9
Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.窥视人类肾草酸钙结石基质:参与尿石症复杂机制的新型蛋白质的特征。
PLoS One. 2013 Jul 24;8(7):e69916. doi: 10.1371/journal.pone.0069916. Print 2013.
10
Diversity in protein profiles of individual calcium oxalate kidney stones.个体草酸钙肾结石中蛋白质谱的多样性。
PLoS One. 2013 Jul 9;8(7):e68624. doi: 10.1371/journal.pone.0068624. Print 2013.